EVIS Bioscience AG
PrivateLast Round
Pre Seed
Feb 20, 2026
Est. Valuation
$15.03M
Total Funding Raised
$1.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EVIS Bioscience AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Pre Seed round in February 2026.
EVIS Bioscience AG is a biotechnology company developing innovative gene delivery systems for targeted and personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVIS Bioscience AG Comparables
Compare EVIS Bioscience AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carmine Therapeutics | 78% | |
| Anjarium Biosciences | 77% | |
| Evox Therapeutics | 76% |
For institutional investors. Book with your work email.
EVIS Bioscience AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 20, 2026 | ||||
| Grant | Dec 1, 2025 |
For institutional investors. Book with your work email.
EVIS Bioscience AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
$870K raised in Pre Seed round.
- Dec 1, 2025
$380K grant received from Innosuisse.
For institutional investors. Book with your work email.
EVIS Bioscience AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EVIS Bioscience AG's valuation, stock price, and market status.
Is EVIS Bioscience AG a public or private company?
EVIS Bioscience AG is a private company.
What is the current stock price of EVIS Bioscience AG?
EVIS Bioscience AG is a private company, so its shares have no public market price. Caplight tracks EVIS Bioscience AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EVIS Bioscience AG worth (valuation)?
EVIS Bioscience AG's valuation is estimated at $15.0M based on funding round data.
Can I buy EVIS Bioscience AG stock?
EVIS Bioscience AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EVIS Bioscience AG's last funding round?
EVIS Bioscience AG's most recent funding round was Pre Seed on February 20, 2026.
Who are the main investors in EVIS Bioscience AG?
Key investors in EVIS Bioscience AG include Innosuisse, Venture Kick.
Will EVIS Bioscience AG IPO soon?
No public IPO plans have been announced for EVIS Bioscience AG.
How can I track EVIS Bioscience AG secondary market activity?
Caplight tracks bids, offers, and trades in EVIS Bioscience AG's shares on secondary markets.